Vanquish Oncology's Series A Round

Vanquish Oncology raised a round of funding on July 17, 2013.

Vanquish Oncology is a drug development company focused on targeting molecular defects in specific cancer cells to create personalized oncology therapeutics for unmet or underserved cancer markets. Th…

Articles about Vanquish Oncology's Series A Round: